Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Viemed Healthcare (VMD) EBITDA Margin (2018 - 2025)

Historic EBITDA Margin for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to 7.85%.

  • Viemed Healthcare's EBITDA Margin fell 18600.0% to 7.85% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.25%, marking a year-over-year increase of 15700.0%. This contributed to the annual value of 5.02% for FY2024, which is 5700.0% down from last year.
  • Latest data reveals that Viemed Healthcare reported EBITDA Margin of 7.85% as of Q3 2025, which was down 18600.0% from 8.08% recorded in Q2 2025.
  • In the past 5 years, Viemed Healthcare's EBITDA Margin registered a high of 12.95% during Q4 2021, and its lowest value of 3.08% during Q2 2022.
  • In the last 5 years, Viemed Healthcare's EBITDA Margin had a median value of 6.3% in 2021 and averaged 6.54%.
  • As far as peak fluctuations go, Viemed Healthcare's EBITDA Margin plummeted by -395300bps in 2021, and later surged by 37900bps in 2024.
  • Over the past 5 years, Viemed Healthcare's EBITDA Margin (Quarter) stood at 12.95% in 2021, then tumbled by -51bps to 6.35% in 2022, then increased by 8bps to 6.85% in 2023, then surged by 55bps to 10.63% in 2024, then fell by -26bps to 7.85% in 2025.
  • Its last three reported values are 7.85% in Q3 2025, 8.08% for Q2 2025, and 6.5% during Q1 2025.